Valion Bio, Inc.
corporate_fare Company Profile
Valion Bio, Inc. (NASDAQ:VBIO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors VBIO SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Valion Bio's Q1 Net Loss Widens to $6.2M on Just $24K Revenue, Signaling Severe Financial Strain
- Valion Bio Reports Soaring Losses, Going Concern Warning, and Nasdaq Non-Compliance Amidst New Equity Line
- Valion Bio Reports Q1 Net Loss of $6.2M, Cash Dwindles to $7.2M Amid High Burn
- Valion Bio's Entolimod™ Program Receives $7M NIAID Funding, Federal Agency to Co-Navigate FDA Submission
show_chartPrice Chart
Loading chart...